![]() Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | ||
Founding Date | Founding Date 2000 | Founding Date 1996 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Heidelberg, DE HQ | Locations Saint-Quentin-Fallavier, FR HQ |
Employees | Employees 76 | Employees 2453% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) £95.9m (FY, 2015) |
Cost of goods | Cost of goods N/A | Cost of goods £43.1m (FY, 2015) |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit £52.8m (FY, 2015) |

Skyepharma is a drug delivery company developing oral and inhalation products.
View company